Aditxt, Inc. Announces Strategic Acquisition of Appili Therapeutics
TipRanksApr 4 17:13 ET
Why Aditxt Stock Is Volatile Today
Aditxt, Inc. (NASDAQ:ADTX) shares are volatile Tuesday after the company announced it will acquire Appili Therapeutics.The Details:Aditxt's wholly owned subsidiary, Adivir, Inc. will acquire all issue
BenzingaApr 2 12:42 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersNexalin Technology (NASDAQ:NXL) stock increased by 47.9% to $2.81 during Tuesday's regular session. The market value of their outstanding shares is at $20.4 million. MSP Recovery (NASDAQ:LIFW)
BenzingaApr 2 12:31 ET
Decoding The Spike: Understanding Aditxt (ADTX) Shares' Significant Increase
Aditxt, Inc. (NASDAQ: ADTX) is observing a notable surge of 25.47% in its shares during the current session, escalating to a price of $3.99. This significant increase in ADTX shares within the US market can be directly attributed to the disclosure of an acquisition agreement. Aditxt (ADTX) officially stated today that it has reached a ...
Stocks TelegraphApr 2 12:05 ET
Canopy Growth, Exact Sciences, Stereotaxis Among Healthcare Movers
Seeking AlphaApr 2 10:00 ET
Express News | Aditxt Shares Resume Trade
Moomoo 24/7Apr 2 09:39 ET
Express News | Adixit Shares Halted On Circuit Breaker To The Downside, Stock Now Up 45.9%
Moomoo 24/7Apr 2 09:37 ET
Aditxt to Buy Biopharmaceutical Company Appili Therapeutics for Undisclosed Amount
By Chris Wack Aditxt said it will buy Appili Therapeutics for an undisclosed amount through a court-approved plan of arrangement under the Canada Business Corporations Act. Aditxt said Tuesday that
WSJApr 2 08:58 ET
Express News | Aditxt Shares Are Trading Higher After the Company Announced It Will Acquire Appili Therapeutics
Moomoo 24/7Apr 2 08:52 ET
Press Release: Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
Assets include the FDA-approved LIKMEZ(TM), the ATI-1701 tularemia vaccine defense program that has been awarded a USD $14 million non-dilutive award from the DoD, and the ATI-1801 topical formulation
Dow JonesApr 2 08:30 ET
Aditxt, Through Adivir Subsidiary, To Acquire All Issued And Outstanding Class A Common Shares Of Appili; Appili Shareholders To Receive 0.002745004 Shares Of Aditxt And $0.0467 For Each Appili Share Held, Representing Total Consideration Of ~$0.0561
Under the terms of the Arrangement Agreement, shareholders of Appili (the "Appili Shareholders") will receive (i) 0.002745004 of a share of common stock (each whole share, an "Aditxt Share") of Aditxt
BenzingaApr 2 07:35 ET
Appili Therapeutics Signs Definitive Agreement to Be Acquired by Aditxt, Inc.
Transaction consideration provides a significant premium to the Appili shareholders Combined enterprise expected to provide enhanced synergies and resources to advance key programs NOT FOR DISTRIBUTIO
GlobeNewswireApr 2 07:30 ET
Evofem Biosciences 4Q Loss/Shr 44c >EVFM
Evofem Biosciences 4Q Loss/Shr 44c >EVFM
Dow JonesMar 27 08:36 ET
Evofem Reports $18.2 Million of Phexxi Net Product Sales in 2023
The company behind Phexxi (lactic acid, citric acid, and potassium bitartrate) vaginal gel, women's health innovator Evofem Biosciences, Inc....
PR NewswireMar 27 08:36 ET
Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI With Medi-Cal
Commercial-stage women's health innovator Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced that it has successfully renegotiated the rebate...
PR NewswireMar 20 08:54 ET
For Women Using GLP-1 Receptor Agonists Who Take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel Is a Logical Solution to Help Prevent Unintended Pregnancy
Use of GLP-1 receptor agonists, or GLP-1s, is skyrocketing in the United States, with more than nine million prescriptions for Ozempic, Wegovy,...
PR NewswireMar 7 07:54 ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) shares increased by 69.4% to $1.46 during Wednesday's pre-market session. The market value of their outstanding shares is at $31.9 million. Creative Medical Tech (NA
BenzingaMar 6 08:07 ET
Aditxt Secures Dawson James for M&A Advisory Role
TipRanksFeb 21 16:49 ET
Aditxt, Inc. CEO's $205K Loan to Bolster Company Growth
TipRanksFeb 16 16:44 ET
Aditxt, Inc. Faces Defaults and Loan Breaches, Negotiates With Lenders
TipRanksFeb 15 16:45 ET
No Data
No Data